Page last updated: 2024-08-26

fibrinogen and Apolipoprotein B-100, Familial Defective

fibrinogen has been researched along with Apolipoprotein B-100, Familial Defective in 59 studies

Research

Studies (59)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (11.86)	18.7374
1990's	29 (49.15)	18.2507
2000's	18 (30.51)	29.6817
2010's	5 (8.47)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Galema-Boers, JAMH; Kruip, MJHA; Roeters van Lennep, JE; Schol-Gelok, S; van Gelder, T; Versmissen, J	1
Cho, G; Douglas, K; El-Ghariani, K; Howell, C; Potok, D; Rintala, T; Taylor, P; Watkins, S	1
Hardersen, R; Hovland, A; Lappegård, KT; Mollnes, TE; Nielsen, EW	1
Avellone, G; Campisi, D; Di Garbo, V; Guarnotta, V; Parrinello, G; Purpura, L; Scaglione, R; Torres, D	1
Armstrong, VW; Helfmann, J; Hintze, E; Konstantinides, S; Koziolek, MJ; Lange, K; Mueller, GA; Rossenbach, J; Schmitto, JD	1
Derfler, K; Goldammer, A; Heinz, G; Hörl, WH; Jansen, M; Stulnig, T; Wiltschnig, S	1
Hutten, BA; Kastelein, JJ; Smilde, TJ; Stalenhoef, AF; Trip, MD; van Wissen, S	1
Chrysohoou, C; Panagiotakos, DB; Pitsavos, C; Skoumas, J; Stefanadis, CI; Toutouza, M; Toutouzas, PK	1
Brettschneider-Meyer, A; Horstkotte, D; Jaeger, BR; Mellwig, KP; Meyer, H; Schmidt, HK; Seidel, D; Walli, AK	1
Andrikopoulos, GK; Fourlas, CA; Kartalis, A; Katsaros, A; Michaelides, AP; Pitsavos, C; Skoumas, I; Stefanadis, CI; Stougiannos, P	1
Broncel, M; Chojnowska-Jezierska, J; Kostka, B; Marczyk, I; Michalska, M; Sikora, J	2
Abruzzese, G; Avellone, G; Campisi, D; De Simone, R; Di Garbo, V; Licata, G; Raneli, G	1
Forbes, CD; Lorimer, AR; Lowe, GD; McArdle, BM; Prentice, CR; Stromberg, P	1
Bremner, WF; Drummond, MM; Forbes, CD; Lawrie, TD; Lowe, GD; Prentice, CR; Third, JL	1
Heidinger, K; Jovin, IS; Múller-Berghaus, G; Taborski, U	1
Branchi, A; Fasoli, A; Gugliandolo, AG; Rovellini, A; Sommariva, D	1
Bønaa, KH; Joakimsen, O; Leren, TP; Ose, L; Russell, D; Stensland-Bugge, E; Tonstad, S	1
Bordin, P; Calabrese, S; Cattin, L; Da Col, PG; Fiotti, N; Fonda, M; Giansante, C; Petrucco, A	1
Azuma, N; Matsugane, T; Nishide, T; Nobuto, T; Nosé, Y; Saito, K; Sasaki, N; Shinomiya, M; Suzuki, M; Yamane, S	1
Aznar, J; Carmena, R; Gil, L; Lluch, I; Martí, R; Martínez, M; Vayá, A	2
Ceska, R; Haas, T; Kvasilová, M; Kvasnicka, J; Procházková, R; Sobra, J	1
Aznar, J; Dalmau, J; Labios, M; Martínez, M; Vayá, A	1
Ganotakis, ES; Mikhailidis, DP; Winder, AF	1
Bambauer, R; Klinkmann, J; Latza, R; Schiel, R	1
Bambauer, R; Keller, HE; Klinkmann, J; Latza, R; Schiel, R	1
Schuff-Werner, P	1
Danielson, BG; Fadul, JE; Linde, T; Sandhagen, B; Vessby, B; Wikström, B	1
de Maat, MP; Kastelein, JJ; Kluft, C; Knipscheer, HC; Kockx, M; Kooistra, T; Princen, HM	1
Crook, MA; Lumb, PJ; Semra, YK; Wierzbicki, AS	1
Arrol, S; Bhatnagar, D; Durrington, PN; Julier, K; Mackness, MI; Morgan, J; Prais, H; Wood, GN	1
Berg, K	1
Aznar, J; Ballesta, A; Dalmau, J; Martí, R; Martínez, M; Vayá, A	1
Seidel, D; Thiery, J	2
Bandinelli, S; Bertolotto, A; Lo Faro, A; Navalesi, R; Penno, G; Ruocco, L	1
Boschetti, C; Cofrancesco, E; Cortellaro, F; Cortellaro, M; Mancini, M; Mariani, M; Paoletti, R	1
Donner, MG; Geiss, HC; Otto, C; Parhofer, KG; Schwandt, P	1
Chik, G; Crook, MA; Lumb, PJ; Wierzbicki, AS	1
Minkenberg, R; Otto, C; Richter, WO; Ritter, MM; Schwandt, P	1
Bo, M; Fabris, F; Fiandra, U; Mercadante, G; Nicolello, MT; Piliego, T	1
Gibson, CA; Matias, MS; Moriarty, PM; Shih, J	1
Alt, E; Banyai, M; Banyai, S; Derfler, K; Falger, J; Jansen, M; Koppensteiner, R	1
Cwalina, L; Herman, ZS; Kalina, Z; Kowalski, J; Lebek, M; Okopien, B; Wisniewska-Wanat, M; Zielinski, M	1
Arber, N; Avitzour, D; Beigel, Y; Berliner, S; Elishkevitz, K; Fusman, R; Hershcovici, T; Rotstein, R; Shapira, I; Zeltser, D	1
Furuhashi, K; Katsube, S; Kitano, S; Kobayashi, J; Maruyama, T; Masuda, M; Shimoda, M; Shinomiya, M	1
Betteridge, DJ; Jay, RH; McCarthy, SN; Rampling, MW	1
Beigel, Y; Djaldetti, M; Fuchs, J; Green, P; Lurie, Y; Snir, M	1
Betteridge, DJ; Jay, RH; Rampling, MW	1
Calabrò, A; Ciuffetti, G; Crepaldi, G; Descovich, GC; Fellin, R; Gaddi, A; Mannarino, E; Rossi, A; Senin, U; Ventura, A	1
Deck, C; Huster, G; Radack, K	1
Gries, FA; Kleophas, W; Leschke, M; Martin, J; Schauseil, S; Schottenfeld, Y; Strauer, BE; Tschöpe, D	1
Ehringer, H; Koppensteiner, R; Minar, E	1
Antwiler, GD; Dau, PC; Lobdell, DD	1
Armstrong, VW; Eisenhauer, T; Janning, G; Schuff-Werner, P; Schütz, E; Seidel, D; Seyde, WC	1
Armstrong, VW; Eisenhauer, T; Schuff-Werner, P; Seidel, D	1
Cerbone, AM; Di Minno, G; Iride, C; Mancini, M; Mattioli, PL; Postiglione, A	1
Bantjes, A; Kempen, HJ; Maaskant, N	1

Reviews

4 review(s) available for fibrinogen and Apolipoprotein B-100, Familial Defective

Article	Year
[Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis]. Zeitschrift fur Kardiologie, 1997, Volume: 86 Suppl 1 Topics: Blood Component Removal; Cholesterol, LDL; Coronary Artery Disease; Fibrinogen; Fractional Precipitation; Heparin; Humans; Hyperlipoproteinemia Type II; Treatment Outcome	1997
[Molecular biology in the diagnosis of cardiovascular diseases]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1998, Jun-10, Volume: 118, Issue:15 Topics: Biomarkers; Cardiovascular Diseases; DNA Mutational Analysis; Fibrinogen; Genetic Variation; Homocysteine; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Molecular Biology; Polymorphism, Genetic; Risk Factors	1998
LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia. Transfusion science, 1993, Volume: 14, Issue:3 Topics: Adolescent; Adult; Blood Component Removal; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Coronary Disease; Female; Fibrinogen; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoprotein(a); Middle Aged; Treatment Outcome	1993
Removal of low-density lipoproteins (LDL) and fibrinogen by precipitation with heparin at low pH: clinical application and experience. Journal of clinical apheresis, 1988, Volume: 4, Issue:2-3 Topics: Blood Component Removal; Fibrinogen; Heparin; Humans; Hydrogen-Ion Concentration; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Methods	1988

Trials

20 trial(s) available for fibrinogen and Apolipoprotein B-100, Familial Defective

Article	Year
Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. International angiology : a journal of the International Union of Angiology, 2010, Volume: 29, Issue:6 Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Azetidines; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Cholesterol; Cholesterol, HDL; Drug Combinations; Ezetimibe, Simvastatin Drug Combination; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Inflammation Mediators; Italy; Male; Middle Aged; Myocardial Infarction; Primary Prevention; Secondary Prevention; Simvastatin; Time Factors; Treatment Outcome; Triglycerides; Ultrasonography	2010
Effect of atorvastatin (80 mg) and simvastatin (40 mg) on plasma fibrinogen levels and on carotid intima media thickness in patients with familial hypercholesterolemia. The American journal of cardiology, 2003, Mar-01, Volume: 91, Issue:5 Topics: Administration, Oral; Adult; Atorvastatin; Biomarkers; Carotid Arteries; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fibrinogen; Follow-Up Studies; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Probability; Pyrroles; Reference Values; Severity of Illness Index; Simvastatin; Treatment Outcome; Tunica Media	2003
[The comparison of simvastatin and atorvastatin effects on hemostatic parameters in patients with hyperlipidemia type II]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2005, Volume: 18, Issue:106 Topics: Aged; Antithrombin III; Atorvastatin; Factor X; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Middle Aged; Pyrroles; Simvastatin; Treatment Outcome	2005
Evaluation of double filtration plasmapheresis, thermofiltration, and low-density lipoprotein adsorptive methods by crossover test in the treatment of familial hypercholesterolemia patients. Artificial organs, 1996, Volume: 20, Issue:4 Topics: Adsorption; Adult; Apolipoprotein A-II; Apolipoproteins B; Apolipoproteins C; Blood Chemical Analysis; Blood Proteins; Cross-Over Studies; Female; Fibrinogen; Filtration; Hot Temperature; Humans; Hyperlipoproteinemia Type II; Immunoglobulin M; Interleukin-1; Lipoprotein(a); Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Plasmapheresis; Triglycerides; Tumor Necrosis Factor-alpha	1996
Effect of HMG-CoA reductase inhibitors on red blood cell membrane lipids and haemorheological parameters, in patients affected by familial hypercholesterolemia. Haemostasis, 1996, Volume: 26 Suppl 4 Topics: Adult; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Blood Viscosity; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Combined Modality Therapy; Enzyme Inhibitors; Erythrocyte Aggregation; Erythrocyte Deformability; Erythrocyte Membrane; Female; Fibrinogen; Hemorheology; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lovastatin; Male; Membrane Lipids; Middle Aged; Phospholipids	1996
Treatment of severe hyperlipidemia: six years' experience with low-density lipoprotein apheresis. Artificial organs, 1996, Volume: 20, Issue:4 Topics: Adsorption; Adult; Aged; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Dextran Sulfate; Female; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Immunosorbents; Lipoprotein(a); Longitudinal Studies; Male; Middle Aged; Plasmapheresis; Triglycerides	1996
Low-density lipoprotein apheresis in the treatment of two patients with coronary heart disease and extremely elevated lipoprotein (a) levels. Artificial organs, 1996, Volume: 20, Issue:4 Topics: Adult; Chi-Square Distribution; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Immunosorbents; Lipoprotein(a); Longitudinal Studies; Male; Plasmapheresis; Triglycerides; White People	1996
Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients. Thrombosis and haemostasis, 1997, Volume: 78, Issue:4 Topics: Adult; Aged; Cholesterol; Clofibric Acid; Double-Blind Method; Female; Fibric Acids; Fibrinogen; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Smoking; Tissue Plasminogen Activator; Treatment Outcome	1997
Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia. Atherosclerosis, 1998, Volume: 138, Issue:1 Topics: Adult; Aged; Aryldialkylphosphatase; Bezafibrate; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cross-Over Studies; Double-Blind Method; Esterases; Female; Fibrinogen; Gemfibrozil; Glycoproteins; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Plasminogen Activators	1998
More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolemia. Atherosclerosis, 1999, Volume: 143, Issue:2 Topics: Adult; Analysis of Variance; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fibrinogen; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Pyrroles; Treatment Outcome	1999
Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Trea Thrombosis and haemostasis, 2000, Volume: 83, Issue:4 Topics: Adult; Aged; Bezafibrate; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fibrinogen; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hypertriglyceridemia; Hypolipidemic Agents; Indoles; Male; Middle Aged; Tissue Plasminogen Activator; Treatment Outcome	2000
Influence of atorvastatin versus simvastatin on fibrinogen and other hemorheological parameters in patients with severe hypercholesterolemia treated with regular low-density lipoprotein immunoadsorption apheresis. Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis, 2000, Volume: 4, Issue:3 Topics: Anticholesteremic Agents; Atorvastatin; Blood Component Removal; Blood Viscosity; Combined Modality Therapy; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hemorheology; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Immunosorbent Techniques; Lipoproteins, LDL; Male; Middle Aged; Plasma Volume; Pyrroles; Simvastatin	2000
Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemia. The American journal of cardiology, 2001, Feb-01, Volume: 87, Issue:3 Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Coronary Artery Disease; Female; Fibrinogen; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Pyrroles; Risk Factors; Simvastatin	2001
Treatment of heterozygous familial hypercholesterolemia: atorvastatin vs simvastatin. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2001, Volume: 11, Issue:1 Topics: Anticholesteremic Agents; Apolipoproteins; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Fibrinogen; Heptanoic Acids; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Pyrroles; Simvastatin; Time Factors; Treatment Outcome; Triglycerides	2001
Effects of fibrates on plasma prothrombotic activity in patients with type IIb dyslipidemia. International journal of clinical pharmacology and therapeutics, 2001, Volume: 39, Issue:12 Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Female; Fenofibrate; Fibric Acids; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Thrombosis; Tissue Plasminogen Activator; Treatment Outcome; Triglycerides	2001
Single LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects. Clinica chimica acta; international journal of clinical chemistry, 2002, Volume: 321, Issue:1-2 Topics: Apolipoproteins; Blood Component Removal; Body Mass Index; C-Reactive Protein; Cholesterol; Female; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Japan; Lipoproteins; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Triglycerides	2002
Lovastatin therapy in heterozygous familial hypercholesterolaemic patients: effect on blood rheology and fibrinogen levels. Journal of internal medicine, 1991, Volume: 230, Issue:1 Topics: Blood Viscosity; Dose-Response Relationship, Drug; Drug Evaluation; Erythrocyte Deformability; Female; Fibrinogen; Heterozygote; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Lovastatin; Male; Middle Aged; Platelet Count	1991
Abnormalities of blood rheology in familial hypercholesterolaemia: effects of treatment. Atherosclerosis, 1990, Volume: 85, Issue:2-3 Topics: Adult; Anticholesteremic Agents; Blood Viscosity; Cholestyramine Resin; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Male; Middle Aged; Naphthalenes; Pravastatin; Rheology	1990
Double-blind multicenter trial on a new medium molecular weight glycosaminoglycan. Current therapeutic effects and perspectives for clinical use. Atherosclerosis, 1990, Volume: 81, Issue:3 Topics: Adult; Aged; Blood Viscosity; Cholesterol; Clinical Trials as Topic; Double-Blind Method; Erythrocyte Deformability; Female; Fibrinogen; Glycosaminoglycans; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type V; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Multicenter Studies as Topic; Triglycerides	1990
The comparative effects of n-3 and n-6 polyunsaturated fatty acids on plasma fibrinogen levels: a controlled clinical trial in hypertriglyceridemic subjects. Journal of the American College of Nutrition, 1990, Volume: 9, Issue:4 Topics: Corn Oil; Dietary Fats; Double-Blind Method; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Fibrinogen; Fish Oils; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Randomized Controlled Trials as Topic	1990

Other Studies

35 other study(ies) available for fibrinogen and Apolipoprotein B-100, Familial Defective

Article	Year
No effect of PCSK9 inhibitors on D-dimer and fibrinogen levels in patients with familial hypercholesterolemia. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 108 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; PCSK9 Inhibitors	2018
Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology. Transfusion medicine (Oxford, England), 2015, Volume: 25, Issue:2 Topics: Adult; Anemia, Sickle Cell; Autoimmune Diseases; Blood Component Removal; Blood Donors; Child; Citrates; Fibrinogen; Health Facilities; Humans; Hyperlipoproteinemia Type II; Leukocyte Reduction Procedures; Lipoproteins; Lymphoma, T-Cell, Cutaneous; Photopheresis; Plasma; Plasma Exchange; Quality Control; Syncope, Vasovagal; Thrombotic Microangiopathies	2015
Hematologic and hemostatic changes induced by different columns during LDL apheresis. Journal of clinical apheresis, 2010, Volume: 25, Issue:5 Topics: Adult; Antithrombin III; Blood Component Removal; Cholesterol, LDL; Female; Fibrinogen; Hemostasis; Homocysteine; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Peptide Hydrolases; Plasminogen Activator Inhibitor 1	2010
Lipid-apheresis improves microcirculation of the upper limbs. Journal of clinical apheresis, 2011, Volume: 26, Issue:4 Topics: Adult; Aged; Arginine; Atrial Natriuretic Factor; Blood Component Removal; Blood Flow Velocity; Endothelin-1; Epinephrine; Erythrocyte Aggregation; Female; Fibrinogen; Hand; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Laser-Doppler Flowmetry; Lipids; Male; Microcirculation; Microscopic Angioscopy; Middle Aged; Norepinephrine; Photoplethysmography	2011
Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia. Metabolism: clinical and experimental, 2002, Volume: 51, Issue:8 Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Blood Component Removal; Cholesterol, LDL; Cost-Benefit Analysis; Female; Fibrinogen; Heptanoic Acids; Heterozygote; Homozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Middle Aged; Prospective Studies; Pyrroles; Triglycerides	2002
Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002). Current medical research and opinion, 2003, Volume: 19, Issue:2 Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Hyperlipoproteinemia Type II; Hypertension; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Smoking	2003
[Coronary heart disease in childhood in familial hypercholesteremia. Maximum therapy with LDL apheresis]. Der Internist, 2003, Volume: 44, Issue:4 Topics: Anticholesteremic Agents; Blood Component Removal; Child; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Coronary Angiography; Coronary Artery Disease; Fibrinogen; Follow-Up Studies; Genetic Carrier Screening; Humans; Hyperlipoproteinemia Type II; Male; Receptors, LDL; Treatment Outcome; Triglycerides	2003
Exercise testing in asymptomatic patients with heterozygous familial hypercholesterolaemia. Coronary artery disease, 2004, Volume: 15, Issue:8 Topics: Adult; Exercise; Exercise Test; Female; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Risk Factors; ROC Curve; Sensitivity and Specificity	2004
One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease. International angiology : a journal of the International Union of Angiology, 2006, Volume: 25, Issue:1 Topics: Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Atorvastatin; Blood Platelets; C-Reactive Protein; Carotid Artery Diseases; Carotid Artery, Common; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Middle Aged; Patient Compliance; Pyrroles; Time Factors; Treatment Outcome; Triglycerides	2006
[Estimation of the correlation between hemostatic parameters and serum lipids in patients with hyperlipidemia type II after simvastatin therapy]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2007, Volume: 22, Issue:127 Topics: Adult; Aged; Antithrombin III; Biomarkers; Blood Coagulation; Cholesterol; Cholesterol, LDL; Factor X; Female; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Reference Values; Simvastatin; Statistics as Topic; Thrombin; Triglycerides	2007
Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia. Lancet (London, England), 1982, Feb-27, Volume: 1, Issue:8270 Topics: Adolescent; Adult; alpha-2-Antiplasmin; Arterial Occlusive Diseases; Blood Viscosity; Child; Female; Fibrinogen; Hematocrit; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Plasminogen Activators; Risk	1982
Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia. Thrombosis and haemostasis, 1980, Feb-29, Volume: 42, Issue:5 Topics: Adolescent; Adult; Arteriosclerosis; Cholesterol; Coronary Disease; Female; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Platelet Aggregation; Thrombosis; Triglycerides	1980
Low-density-lipoprotein apheresis. Lancet (London, England), 1995, Jul-08, Volume: 346, Issue:8967 Topics: Adsorption; Blood Coagulation Factors; Blood Component Removal; Cholesterol, LDL; Coronary Artery Disease; Coronary Thrombosis; Dextran Sulfate; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Lipoprotein(a)	1995
Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia. Thrombosis and haemostasis, 1993, Aug-02, Volume: 70, Issue:2 Topics: Adult; Aged; Bezafibrate; Cholesterol, Dietary; Combined Modality Therapy; Female; Fenofibrate; Fibrinogen; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipids; Lovastatin; Male; Middle Aged; Pravastatin; Simvastatin	1993
Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arteriosclerosis, thrombosis, and vascular biology, 1996, Volume: 16, Issue:8 Topics: Adolescent; Anthropometry; Apolipoproteins B; Arteriosclerosis; Carotid Arteries; Carotid Stenosis; Child; Female; Fibrinogen; Homocysteine; Humans; Hyperlipoproteinemia Type II; Lipoprotein(a); Male; Norway; Puberty; Risk Factors; Sex Factors; Ultrasonography	1996
Activation of coagulation by a LDL-apheresis device. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1996, Volume: 7, Issue:4 Topics: Aged; Antithrombin III; Blood Coagulation; Blood Component Removal; Cellulose; Dextrans; Female; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Partial Thromboplastin Time; Peptide Hydrolases; Sulfates	1996
Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin. Thrombosis research, 1996, Sep-01, Volume: 83, Issue:5 Topics: Adult; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, Dietary; Combined Modality Therapy; Diet, Fat-Restricted; Erythrocyte Deformability; Erythrocyte Membrane; Female; Fibrinogen; Hemorheology; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Membrane Lipids; Middle Aged; Phospholipids	1996
[The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia]. Casopis lekaru ceskych, 1996, Jul-26, Volume: 135, Issue:13 Topics: Adult; Aged; Female; Fenofibrate; Fibrinogen; Heterozygote; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Male; Middle Aged	1996
Hemorheological profile in patients with cardiovascular risk factors. Haemostasis, 1996, Volume: 26 Suppl 4 Topics: Adolescent; Adult; Blood Viscosity; Cardiovascular Diseases; Child; Child, Preschool; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Heterozygote; Humans; Hyperlipoproteinemia Type II; Hypertension; Male; Risk Factors; Sex Factors	1996
Comment on: effect of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia. Atherosclerosis, 1996, Dec-20, Volume: 127, Issue:2 Topics: Anticholesteremic Agents; Fibrinogen; Follow-Up Studies; Hemorheology; Humans; Hyperlipoproteinemia Type II; Lovastatin; Pravastatin; Simvastatin	1996
Effects of LDL apheresis on blood rheology in two patients with homozygous familial hypercholesterolaemia. Blood purification, 1997, Volume: 15, Issue:3 Topics: Adsorption; Adult; Blood Component Removal; Blood Viscosity; Cholesterol, LDL; Dextran Sulfate; Fibrinogen; Hemorheology; Homozygote; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Myocardial Ischemia; Receptors, LDL	1997
Effect of atorvastatin on plasma fibrinogen. Lancet (London, England), 1998, Feb-21, Volume: 351, Issue:9102 Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Female; Fibrinogen; Heptanoic Acids; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Male; Middle Aged; Pyrroles	1998
Plasma thrombomodulin is not increased in familial hypercholesterolemic children with rheological alterations. Clinical hemorheology and microcirculation, 1998, Volume: 19, Issue:2 Topics: Adolescent; Apolipoprotein A-I; Apolipoproteins B; Blood Viscosity; Child; Child, Preschool; Cholesterol; Cholesterol, LDL; Erythrocyte Aggregation; Female; Fibrinogen; Hemorheology; Humans; Hyperlipoproteinemia Type II; Male; Thrombomodulin; Triglycerides	1998
Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks. Metabolism: clinical and experimental, 2001, Volume: 50, Issue:2 Topics: Arteriosclerosis; Blood Viscosity; Cross-Sectional Studies; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Lipoproteins; Male; Middle Aged; Risk Factors	2001
C-reactive protein and other markers of inflammation among patients undergoing HELP LDL apheresis. Atherosclerosis, 2001, Volume: 158, Issue:2 Topics: Blood Component Removal; C-Reactive Protein; Female; Fibrinogen; Heparin; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins, LDL; Male; Middle Aged; Prospective Studies	2001
Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment. Atherosclerosis, 2001, Volume: 159, Issue:2 Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Blood Viscosity; Combined Modality Therapy; Erythrocyte Aggregation; Female; Fibrinogen; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Plasmapheresis; Probability; Prospective Studies; Pyrroles; Rheology; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome	2001
The erythrocyte adhesiveness/aggregation test to reveal real-time information of rheological relevance in patients with familial and primary hypercholesterolemia before and following plasma exchange. Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis, 2002, Volume: 6, Issue:2 Topics: Adhesiveness; Adult; Aged; Cholesterol; Erythrocyte Aggregation; Female; Fibrinogen; Globulins; Hemorheology; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle Aged; Plasma Exchange	2002
[Extracorporeal plasma therapy in disorders of lipid metabolism: report of experiences with the H.E.L.P. system]. Der Internist, 1992, Volume: 33, Issue:1 Topics: Adult; Blood Component Removal; Cholesterol, LDL; Combined Modality Therapy; Coronary Artery Disease; Female; Fibrinogen; Heparin; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoprotein(a); Lipoproteins; Lipoproteins, LDL	1992
Blood rheology and fibrinogen in children with familial hypercholesterolaemia. Atherosclerosis, 1991, Volume: 91, Issue:1-2 Topics: Adolescent; Blood Viscosity; Child; Child, Preschool; Erythrocyte Aggregation; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Humans; Hyperlipoproteinemia Type II; Male	1991
[Acute effects of extracorporeal LDL cholesterol and fibrinogen elimination on blood rheology and microcirculation]. Deutsche medizinische Wochenschrift (1946), 1990, Jan-05, Volume: 115, Issue:1 Topics: Adult; Blood Gas Monitoring, Transcutaneous; Blood Viscosity; Cholesterol, LDL; Coronary Disease; Fibrinogen; Heparin; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Oxygen; Rheology	1990
Effect of lovastatin on hemorheology in type II hyperlipoproteinemia. Atherosclerosis, 1990, Volume: 83, Issue:1 Topics: Aged; Arteriosclerosis; Blood Viscosity; Cholesterol; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Platelet Aggregation; Rheology; Triglycerides	1990
Reduction of low-density lipoproteins with dextran sulfate in patients with familial hypercholesterolemia. Journal of clinical apheresis, 1988, Volume: 4, Issue:1 Topics: Adult; Cholesterol; Cholesterol, LDL; Complement System Proteins; Dextran Sulfate; Dextrans; Fibrinogen; Fractional Precipitation; Humans; Hyperlipoproteinemia Type II; Immunoglobulins; Lipoproteins, VLDL; Male; Middle Aged; Renal Dialysis	1988
Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). European journal of clinical investigation, 1989, Volume: 19, Issue:1 Topics: Adult; Blood Viscosity; Chemical Precipitation; Coronary Disease; Erythrocyte Aggregation; Extracorporeal Circulation; Female; Fibrinogen; Heparin; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Middle Aged; Muscles; Oxygen Consumption; Rheology	1989
Platelet fibrinogen binding in familial hypercholesterolemia. Advances in experimental medicine and biology, 1987, Volume: 210 Topics: Adenosine Diphosphate; Adolescent; Adult; Blood Platelets; Child; Female; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Male; Platelet Aggregation; Platelet Membrane Glycoproteins; Protein Binding; Thromboxanes; Ticlopidine	1987
Removal of low density lipoprotein from blood plasma using cross-linked, sulfated polyvinylalcohol. Atherosclerosis, 1986, Volume: 62, Issue:2 Topics: Adult; Cholesterol; Cross-Linking Reagents; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Particle Size; Polyvinyl Alcohol; Protein Binding; Sulfuric Acids	1986